Home From Drew Altman

From Drew Altman

Drew Altman is president and chief executive officer of KFF, a position he has held for more than 30 years since founding the modern-day KFF organization in the 1990s. He is a leading expert on national health policy issues and an innovator in health journalism and the nonprofit field.

View full bio | Read Dr. Altman's Beyond the Data columns

Photo of Drew Altman

President’s Message

“KFF is an independent source of health policy research, polling, and journalism. We have four major program areas: KFF Policy; KFF Polling; KFF Health News (formerly Kaiser Health News); and KFF Social Impact Media, which conducts specialized public health information campaigns. Learn more about the organization. 

What’s unique about KFF, however, can’t be found in any description of our programs because we’re more than a sum of our parts. KFF is a one-of-a-kind information organization. Not a policy research organization. Not a polling organization. And not a news organization. But rather, a unique combination of all three. That’s the vision behind KFF, and it's this combination that allows us to leverage our combined expertise and assets to play our national role on health policy.”

Read more

Beyond the Data

In his “Beyond the Data” columns, Dr. Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.

Drew Altman, KFF President and CEP is quoted on this card saying, "People are bewildered by a supercharged and polarized debate about vaccines and no longer know where to turn for scientific information they can rely on ... The vaccines are not the culprit—we and the state of our politics and the distrust in science and our scientific institutions they breed are."

The Problem Isn’t Trust in Vaccines, It’s That People Don’t Know Who to Trust

In a new “Beyond the Data” column, Dr. Altman analyzes years of KFF polling on vaccines in light of the current controversies about them. The real problem, he says, is not lack of public confidence in the safety of vaccines — few say they are unsafe — it’s that polarization and misinformation have eroded confidence in what’s true or not, and in scientific institutions people used to rely on for the facts.

View All Beyond the Data Columns

View the Latest: From Drew Altman

Filter

List Grid

251 - 260 of 324 Results

  • High Health-Care Prices: More Talk Than Action

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Drew Altman explores how price is the major factor that distinguishes the cost of our health care system from those in other developed nations, yet most efforts in the U.S. to address health-care costs don’t focus on price much at all.

  • Which Path for Health-Care Politics in 2015?

    From Drew Altman

    This was published as a Wall Street Journal Think Tank column on January 6, 2015. Yogi Berra said that when you come to a fork in the road, take it. It will be that kind of year for health-care politics. The status quo is not an option.

  • Medicaid Expansion in Red States

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman explains that Tennessee Gov. Bill Haslam's decision on Medicaid expansion via the Affordable Care Act is the latest sign of pragmatism slowly winning over ideology in red states.

  • Our Fragmented Approach to Health-Care Costs

    From Drew Altman

    In his latest column for The Wall Street Journal's Think Tank, Drew Altman discusses this week's Centers for Medicare and Medicaid Services report on health spending and assesses the current effort to control health-care costs.

  • Poll: Ebola Was a Bigger Story Than the Midterms

    From Drew Altman

    For The Wall Street Journal’s Think Tank, Drew Altman discusses what the public was more concerned about in November: Ebola or the results of the midterm elections.

  • How 13 Million Americans Could Lose Insurance Subsidies

    From Drew Altman

    This was published as a Wall Street Journal Think Tank column on November 19, 2014. Kaiser Family Foundation calculations of how many Americans could lose subsidies in 2016 depending on the Supreme Court’s ruling in King v. Burwell. The Supreme Court is expected to rule next year on King v.

  • What to Expect From the Next Congress on the ACA

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman explains how Republican control of Congress will likely bring challenges to the Affordable Care Act in two flavors.

  • How the Midterms Factor Into Medicaid Expansion

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman discusses how Democratic victories in several close gubernatorial races on Tuesday could revive efforts to expand Medicaid.